|
UBE2D3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.76470015956465E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.39299715995867E-11 |
| Normal-vs-Stage2 |
5.578100E-03 |
| Normal-vs-Stage3 |
1.199120E-03 |
| Normal-vs-Stage4 |
4.796400E-02 |
| Stage1-vs-Stage2 |
1.962800E-01 |
| Stage1-vs-Stage3 |
5.198800E-01 |
| Stage1-vs-Stage4 |
4.391200E-01 |
| Stage2-vs-Stage3 |
5.795000E-01 |
| Stage2-vs-Stage4 |
8.703200E-01 |
| Stage3-vs-Stage4 |
7.814000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.24789956146287E-10 |
| Normal-vs-AfricanAmerican |
8.77810000021739E-07 |
| Normal-vs-Asian |
7.798300E-02 |
| Caucasian-vs-AfricanAmerican |
4.786000E-01 |
| Caucasian-vs-Asian |
6.977600E-01 |
| AfricanAmerican-vs-Asian |
5.148200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.21329613023136E-11 |
| Normal-vs-Female |
1.98188999999127E-05 |
| Male-vs-Female |
4.604100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.10780000015265E-07 |
| Normal-vs-Extreme_Weight |
1.29150001804135E-09 |
| Normal-vs-Obese |
2.64129999982821E-07 |
| Normal-vs-Extreme_Obese |
1.019830E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.850600E-01 |
| Normal_Weight-vs-Obese |
4.995200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.653200E-01 |
| Extreme_Weight-vs-Obese |
3.542200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.998600E-01 |
| Obese-vs-Extreme_Obese |
7.120600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.321600E-03 |
| Normal-vs-Age(41-60Yrs) |
3.31030000078059E-08 |
| Normal-vs-Age(61-80Yrs) |
5.10039788181871E-11 |
| Normal-vs-Age(81-100Yrs) |
4.35600000003866E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.097000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.135800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.848200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.991590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.890800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.511600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.27470273120412E-11 |
| Normal-VS-Type2 PRCC |
1.14420000030258E-07 |
| Normal-VS-KIRP CIMP |
1.360290E-02 |
| Normal-VS-Unclassified PRCC |
3.569400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.917000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.082400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.367000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.085200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.116000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.107000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.52850004770033E-09 |
| Normal-vs-N1 |
1.464300E-02 |
| Normal-vs-N2 |
2.567300E-04 |
| N0-vs-N1 |
2.862400E-01 |
| N0-vs-N2 |
7.602000E-01 |
| N1-vs-N2 |
4.937200E-01 |
|
|
